Detailed price information for Cyclerion Therapeutics Inc (CYCN-Q) from The Globe and Mail including charting and trades.

Late-onset depression is increasingly recognized as a major challenge in older cancer survivors, who show a higher prevalence ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

Commentary: This isn’t a lifetime “ban.” It’s a delay that gives kids time to grow the emotional and cognitive skills needed.

Short-form video is dominant on social media, and so many of us are constantly scrolling as our algorithm feeds us ...

Kim, a 29-year-old office worker, recently reset his YouTube algorithm. A few months ago, after he happened to watch videos ...

Having battled postpartum depression twice, biotech entrepreneur and neuroscientist Dr Clarissa Yates is developing a blood ...

The U.S. surgeon general issued a 2023 advisory warning that kids spending more than three hours daily on social media face ...

Makatsaria and LivaNova’s leadership outlined the company’s plan for growth during a November Investor Day event. He spoke to ...

The mere ability to create such images suggests just how harmful it is to remove guardrails on generative AI.

Imagine you’re at a bustling dinner party filled with laughter, music, and clinking silverware. You’re trying to follow a ...